Past Press Releases - Gastrotech Pharma A/S

February 11, 2008
Gastrotech completes $6 million Series D fundraising
Gastrotech Pharma, a clinical stage biopharmaceutical company with a focus on the medical applications of gastrointestinal hormones, has successfully completed a $6 million Series D fundraising round. More

January 29, 2008
Gastrotech signs licensing agreement with Eli Lilly
Gastrotech signs licensing agreement with Eli Lilly following positive clinical data on compound for Irritable Bowel Syndrome More

November 4, 2005
DOR BioPharma executes Letter of Intent for acquisition of Gastrotech Pharma
DOR BioPharma, Inc. announced today that it has signed a binding letter of intent to acquire Gastrotech Pharma A/S, a private Danish biotechnology company based in Copenhagen, Denmark. More